News | April 17, 2007

Siemens' 350th 3T MagnetomTrio MRI Installed

April 18, 2007 - Siemens Medical Solutions recently installed its 350th 3T MAGNETOM Trio magnetic resonance imaging (MRI) scanner at South Jersey Radiology Associates P.A. of Voorhees, NJ.

With this installation, the high-field imaging system is demonstrating that it is not only a research tool, but that it can also make an impact in clinical imaging. Additionally, the scanner is one of more than 175 worldwide 3T systems that use Siemens Medical Solutions proprietary Tim (Total imaging matrix) coil architecture, which eliminates the need for patient repositioning and manual coil changes during scans while significantly enhancing image quality.

“The Trio will allow us to advance to the next level by imaging those regions that are still problematic at 1.5T: small joints such as the wrist, forefoot and fingers,” said William F. Muhr, Jr., MD, a radiologist at South Jersey Radiology Associates P.A. “The 3T field strength moves our neuroimaging to the next level with diffusion tensor imaging and fiber tracking. The magnet will also benefit patients with renal impairments who cannot tolerate as much gadolinium contrast. The increased signal-to-noise ratio at 3T allows us to perform body imaging and MRA at reduced contrast doses. While performing these applications, the MAGNETOM Trio also excels at routine knee, hip, spine and brain imaging, allowing us to run a full patient schedule right out of the gate.”

The MAGNETOM Trio meets a wide range of imaging needs, from routine clinical use, to high-end research, combining the system’s fast gradients with one of the largest field-of-view acquisitions and the highest 3T magnet homogeneity. Siemens’ Tim technology enables the MAGNETOM Trio to address challenges encountered with other 3T systems, without compromising image quality. The high signal-to-noise ratio of the MAGNETOM Trio, in combination with Tim technology, enables reduced scan times, which consequently reduces motion artifacts, improves patient comfort and helps increase patient throughput.

“The success of MAGNETOM Trio can be attributed to its excellent performance in all radiological settings, from neurology and orthopedics to angiography and abdominal imaging,” said Nancy Gillen, vice president, MR division, Siemens Medical Solutions. “The Trio has brought advanced 3T MRI to not only leading academic medical centers but to diagnostic imaging centers and smaller hospitals as well. And our patented Tim technology continues to yield innovations as exemplified by the new generation of Siemens MRI systems.”

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Contrast Media | August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
Guerbet Announces Plans to Streamline Contrast Media Portfolio, gadolinium MRI contrast
News | Contrast Media | July 18, 2017
July 18, 2017 — Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabri
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
FDA says gadolinium retention in the brain is not a safety issue
Feature | Magnetic Resonance Imaging (MRI) | May 25, 2017
A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast agents for...
Targeted MRI Could Pinpoint Aggressive Prostate Cancers Before They Spread

The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017

News | Prostate Cancer | May 24, 2017
A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has engineered a...
Scientists Develop Novel Chemical Dye to Improve MRI Liver Cancer Imaging
News | Magnetic Resonance Imaging (MRI) | May 03, 2017
May 3, 2017 — Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based ...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new...
Overlay Init